MARKET Down 10.2% Health insurers 中文

Insurers slide as Medicare proposes recovering billions through Advantage plan audits

By · AI-assisted, human-reviewed and edited · · Updated · 14 sources · Fact-checked · 6 min read (7 min with all details)

Why did health insurer stocks fall two days in a row?

On Nov 16, after the market closed, the government proposed to recover more money from Medicare Advantage plans by applying the error rate found in a sample of audited records to a whole contract, for payment years from 2018 on; CMS estimates about $9.2 billion in annualized recoveries. Insurers fell on Tuesday and Wednesday and were lower again on Thursday, led by UnitedHealth and Humana. It is a proposal, open for comment, and a court struck down an earlier version last year.

Health insurers
▼ 10.2%
UnitedHealth since Monday
▼ 19.8%
Humana since Monday
▼ 17.6%
CMS recovery estimate
~$9.2B annualized
Humana Medicare Advantage share
77% of 2025 revenue

Closing prices for Nov 16, 17, 18 and 19, 2026, from Yahoo Finance and CNBC. The group move is the median two-day change of the seven insurers listed, Nov 16 to Nov 18. Market values use the share counts on each company's latest 10-Q cover (our calculation).

Health insurers fell on Tuesday and Wednesday, and were lower again on Thursday, after the government proposed a way to claw back more money from Medicare Advantage plans. The plan revives an approach a court struck down in 2025, and it is only a proposal: comments are open, and CMS can change it before it becomes final.

What happened

The Centers for Medicare & Medicaid Services (CMS) filed the proposal, a broad anti-fraud rule it calls CRUSH, on Monday, Nov 16, at 4:15 p.m. ET, after the market closed. Insurers fell on Tuesday and again on Wednesday.

  • UnitedHealth closed at $349.91 on Wednesday, down 15.1% over the two days, and Humana at $385.78, down 16.4%. That is about $56 billion of UnitedHealth’s market value and about $9 billion of Humana’s (our calculation).
  • They were lower again on Thursday. UnitedHealth closed at $330.48, down 5.6% on the day and 19.8% from Monday’s close, and Humana at $380.00, down 1.5% and 17.6%; Cigna fell 4.3%, Centene 2.8% and Elevance 2.7%. The broader market fell too: the S&P 500 tracker was down 2.0% (CNBC, Yahoo Finance).
  • The other large insurers fell less: Molina 11.4%, Elevance 10.2%, Centene 9.8%, CVS Health 8.2% and Cigna 4.9%. The S&P 500 tracker (SPY) fell 1.3%.
  • CMS estimates $90.2 billion in Medicare Advantage audit recoveries over 2027–2036, equivalent to about $9.2 billion annualized.

Two-day change after CMS's proposal, Nov 16 to Nov 18, 2026 (%)

UnitedHealth and Humana fell more than 15%; the S&P 500 tracker fell 1.3%.

HumanaHumana: −16.4% (Insurers and indexes)−16.4%UnitedHealthUnitedHealth: −15.1% (Insurers and indexes)−15.1%MolinaMolina: −11.4% (Insurers and indexes)−11.4%ElevanceElevance: −10.2% (Insurers and indexes)−10.2%CenteneCentene: −9.8% (Insurers and indexes)−9.8%CVS HealthCVS Health: −8.2% (Insurers and indexes)−8.2%CignaCigna: −4.9% (Insurers and indexes)−4.9%Health care ETF (XLV)Health care ETF (XLV): −3.6% (Insurers and indexes)−3.6%S&P 500 tracker (SPY)S&P 500 tracker (SPY): −1.3% (Insurers and indexes)−1.3%HumanaHumana: −16.4% (Insurers and indexes)−16.4%UnitedHealthUnitedHealth: −15.1% (Insurers and indexes)−15.1%MolinaMolina: −11.4% (Insurers and indexes)−11.4%ElevanceElevance: −10.2% (Insurers and indexes)−10.2%CenteneCentene: −9.8% (Insurers and indexes)−9.8%CVS HealthCVS Health: −8.2% (Insurers and indexes)−8.2%CignaCigna: −4.9% (Insurers and indexes)−4.9%Health care ETF (XLV)Health care ETF (XLV): −3.6% (Insurers and indexes)−3.6%S&P 500 tracker (SPY)S&P 500 tracker (SPY): −1.3% (Insurers and indexes)−1.3%
Yahoo Finance closing prices, Nov 16 and Nov 18, 2026, checked against CNBC; our calculation. Closing-price changes, excluding dividends.
Show the data table
Company or index Change (%)
Humana -16.4
UnitedHealth -15.1
Molina -11.4
Elevance -10.2
Centene -9.8
CVS Health -8.2
Cigna -4.9
Health care ETF (XLV) -3.6
S&P 500 tracker (SPY) -1.3
The moves, in figures

Closes (Yahoo Finance, checked against CNBC), Nov 16 → Nov 17 → Nov 18, 2026: UnitedHealth $412.02 → $389.68 (−5.4%) → $349.91 (−10.2%); Humana $461.25 → $443.34 (−3.9%) → $385.78 (−13.0%); Molina $233.09 → $221.21 → $206.56; Elevance $446.28 → $433.93 → $400.84; Centene $74.77 → $72.55 → $67.45; CVS Health $88.59 → $85.81 → $81.35; Cigna $300.16 → $294.06 → $285.37; Health Care Select Sector SPDR (XLV) $187.88 → $185.24 → $181.17; SPY $739.95 → $732.44 → $730.20. Market value lost (our calculation): UnitedHealth 896,022,611 shares (10-Q cover, outstanding Oct 30, 2026) × $62.11 = about $55.7 billion; Humana 120,103,250 shares (10-Q cover, outstanding Sep 30, 2026) × $75.47 = about $9.1 billion. Closes on Nov 19 (Yahoo Finance, checked against CNBC; change from the Nov 18 close): UnitedHealth $330.48 (−5.6%); Humana $380.00 (−1.5%); Molina $203.34 (−1.6%); Elevance $390.16 (−2.7%); Centene $65.58 (−2.8%); CVS Health $80.04 (−1.6%); Cigna $273.04 (−4.3%); XLV $177.46 (−2.0%); SPY $715.87 (−2.0%). From the Nov 16 close: UnitedHealth −19.8%, Humana −17.6%. Federal Register: document 2026-23461, filed for public inspection Nov 16, 2026 at 4:15 p.m. ET, published Nov 19 (91 FR 74680); comments close Jan 19, 2027. CMS rule, impact analysis: “the annualized monetized transfers from MA organizations to CMS would be approximately $9.2 billion”; “the estimated recovery amount from 2027 through 2036 is $90.2 billion”. Fact sheet: about “$9 billion per payment year in MA program overpayments”; “nearly $90 billion in Federal budget savings” across the rule’s quantified provisions, 2027 to 2036.

What the proposal would change

Medicare pays private Medicare Advantage plans more for members whose diagnoses show them to be sicker. In its audits, called Risk Adjustment Data Validation (RADV), CMS checks a sample of members’ medical records and counts diagnoses the records don’t support as overpayments.

How a Medicare Advantage audit would work under the proposal

CMS proposes to reissue rules that let it apply a sample's findings to all enrollees in the audited contract, for payment year 2018 onward.

  1. 1CMS picks a sampleA statistically valid sample of enrollees from one audited Medicare Advantage contract
  2. 2Records are checkedThe diagnoses the plan reported for payment are compared with CMS's review of those enrollees' medical records
  3. 3The error is measuredGaps between the condition codes the plan used for payment and those CMS assigns from the records become an average change in risk score
  4. 4Extrapolated within the contractThat average can be used to estimate the total payment error for all enrollees in the contract the sample came from
  5. 5The plan repaysThe plan returns the improper payments as CMS specifies; it can dispute the findings through an appeals process

Source: CMS proposed rule CMS-6098-P (Federal Register public inspection document 2026-23461), Medicare Advantage RADV reforms; proposed §§ 422.310(e) and 422.311(a).

  • CMS proposes to apply the error rate found in an audit’s sample to the whole contract, for payment year 2018 and later, instead of recovering only what it finds in the sampled records.
  • CMS proposes not to apply an offset it had said, in 2012, it would use to account for unsupported diagnoses in traditional Medicare’s own claims data. CMS says it never calculated or applied one.
  • Plans would have to return audit-identified improper payments as CMS specifies. They could request a hardship exception for extraordinary circumstances preventing timely medical-record submission. CMS also proposes mandatory reporting of suspected or substantiated fraud, waste and abuse, and Original Medicare enrollment for eligible providers and suppliers billing Medicare Advantage, except PACE plans.
The proposal, in its words

Proposed rule (public inspection version), section on RADV reforms: “We are proposing to reissue provisions concerning the use of extrapolation in RADV audits and our decision not to apply an FFS Adjuster when calculating RADV overpayments due to a U.S. District Court for the Northern District of Texas vacating, for procedural reasons, similar provisions of a CMS final rule published February 1, 2023.” It would “apply extrapolation in RADV audits for payment year 2018 and subsequent payment years, using CMS published payment error calculation methodologies”. On the adjuster: “CMS never calculated or implemented an FFS adjuster for any RADV audits.” Fact sheet: CMS “would not apply a fee-for-service (FFS) adjuster, would determine the applicable sampling methodology” and “would begin extrapolation of audit findings with payment year (PY) 2018 audits.”

Why insurers have fought it

This is the second attempt. CMS finalized extrapolation without the adjuster in a rule published on Feb 1, 2023, and Humana sued. On Sep 25, 2025, a federal court in Texas vacated that rule on procedural grounds, finding it was not a “logical outgrowth” of the 2018 proposal, without ruling on Humana’s other arguments, according to the law firm Crowell & Moring. CMS appealed on Nov 21, 2025, and the appeal is pending.

  • When the 2023 rule was finalized, the insurers’ trade group AHIP called it “unlawful and fatally flawed”. Insurers have argued that the payment rates are set from traditional Medicare data that contain unsupported diagnoses too, so auditing plans without an adjuster holds them to a stricter standard.
  • CMS’s answer, in the new proposal, is that the law’s “actuarial equivalence” and “same methodology” requirements do not apply to a plan’s duty to report and return improper payments.
  • We found no statement on the new proposal in UnitedHealth’s or Humana’s SEC filings or press releases through Thursday’s close; Humana’s only filing since Monday, an 8-K on Nov 17, concerns a debt tender offer.

Who is most exposed

Humana depends on Medicare Advantage more than its large rivals. In 2025 its individual and group Medicare Advantage premiums were $99.4 billion, 77% of its revenue, according to its annual report.

  • UnitedHealth had 8.4 million Medicare Advantage members at the end of 2025; its broader Medicare & Retirement business, which also includes Medicare supplement and standalone Part D products, generated $171.3 billion, or 38% of total revenue, according to its annual report.
  • The proposal applies to audits of past payment years, from 2018 on, and CMS has not said how much any one company would owe.

What analysts say

Analysts at Oppenheimer said they believed “CMS will be subject to the same legal challenges that it faced in 2025”, Yahoo Finance reported. They expect recoveries to be “concentrated in 2028–2030”, and said that “even if the rule were implemented as is, and it were upheld by the courts,” they “believe plans would incorporate the prospective cost into bids rather than absorb an unchanged recurring earnings burden.”

What happens next

  • Jan 19, 2027: the comment deadline. The proposal was published in the Federal Register on Nov 19 (91 FR 74680), starting a 60-day comment period.
  • Date not set: the appeals court’s decision on CMS’s appeal of the 2025 ruling (Humana v. Kennedy, Fifth Circuit, No. 25-11293).
  • Date not set: any final rule and changes CMS makes after considering comments. CMS has announced no finalization date.

What to watch next

Jan 19, 2027
The comment deadline. The proposal was published in the Federal Register on Nov 19 (91 FR 74680), starting a 60-day comment period.
Date not set
The appeals court's decision in Humana v. Kennedy, CMS's appeal of the 2025 ruling that struck down the earlier version of the rule.
Date not set
Any final rule and changes CMS makes after considering comments. CMS has announced no finalization date.

Quick questions

What is a RADV audit?

Risk Adjustment Data Validation is how Medicare checks what it pays private Medicare Advantage plans. Plans are paid more for sicker members, based on the diagnoses they report; in an audit, CMS checks a sample of members' medical records to see whether they support those diagnoses, and treats unsupported ones as overpayments.

What does extrapolation mean here?

Applying the error rate found in the audited sample to the whole contract, rather than recovering only the overpayments found in the sampled records. CMS proposes to do this for payment year 2018 and later.

What is the fee-for-service adjuster?

An offset to an audit's recovery amount that CMS said in 2012 it would apply, to account for diagnoses in traditional Medicare's own claims data that would also lack support. CMS says it never calculated or applied one, and it proposes not to. Insurers have argued that without it, they are held to a stricter standard than the data their payments are based on.

Is the rule final?

No. It is a proposed rule, with a 60-day comment period after its publication in the Federal Register on Nov 19. The comment deadline is Jan 19, 2027, and CMS can revise the proposal before finalizing it.

Quoting this? You may quote short excerpts under our reuse policy. Please credit WhyMyStockMoved.com and link to this page.